The need for early Kasai portoenterostomy: a Western Pediatric Surgery Research Consortium study.
Biliary atresia
Kasai portoenterostomy
Liver transplant
Transplant-free survival
Journal
Pediatric surgery international
ISSN: 1437-9813
Titre abrégé: Pediatr Surg Int
Pays: Germany
ID NLM: 8609169
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
accepted:
20
11
2021
pubmed:
3
12
2021
medline:
12
1
2022
entrez:
2
12
2021
Statut:
ppublish
Résumé
The purpose of this study was to investigate factors impacting transplant-free survival among infants with biliary atresia. A multi-institutional, retrospective cohort study was performed at nine tertiary-level children's hospitals in the United States. Infants who underwent Kasai portoenterostomy (KP) from January 2009 to May 2017 were identified. Clinical characteristics included age at time of KP, steroid use, surgical approach, liver pathology, and surgeon experience. Likelihood of transplant-free survival (TFS) was evaluated using logistic regression, adjusting for patient and surgeon-level factors. Secondary outcomes at 1 year included readmission, cholangitis, reoperation, mortality, and biliary clearance. Overall, 223 infants underwent KP, and 91 (40.8%) survived with their native liver. Mean age at surgery was 63.9 days (± 24.7 days). At 1 year, 78.5% experienced readmission, 56.9% developed cholangitis, 3.8% had a surgical revision, and 5 died. Biliary clearance at 3 months was achieved in 76.6%. Controlling for patient and surgeon-level factors, each additional day of age toward operation was associated with a 2% decrease in likelihood of TFS (OR 0.98, 95% CI 0.97-0.99). Earlier surgical intervention by Kasai portoenterostomy at tertiary-level centers significantly increases likelihood for TFS. Policy-level interventions to facilitate early screening and surgical referral for infants with biliary atresia are warranted to improve outcomes.
Identifiants
pubmed: 34854975
doi: 10.1007/s00383-021-05047-1
pii: 10.1007/s00383-021-05047-1
pmc: PMC8742784
mid: NIHMS1764803
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
193-199Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR001854
Pays : United States
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
J Hepatol. 2013 Jun;58(6):1209-17
pubmed: 23402746
J Gastrointest Surg. 2014 Apr;18(4):690-700
pubmed: 24297652
Liver Transpl. 2017 Jan;23(1):96-109
pubmed: 27650268
Chang Gung Med J. 2006 May-Jun;29(3):234-9
pubmed: 16924884
Pediatrics. 2009 May;123(5):1280-6
pubmed: 19403492
Am J Surg. 2016 Jan;211(1):59-63
pubmed: 26542187
Eur J Surg Oncol. 2016 Oct;42(10):1483-90
pubmed: 27378161
BMC Pediatr. 2018 Apr 2;18(1):119
pubmed: 29606115
J Pediatr. 2017 Aug;187:253-257
pubmed: 28746031
J Pediatr Gastroenterol Nutr. 2019 Oct;69(4):416-424
pubmed: 31335841
JAMA. 2020 Mar 24;323(12):1141-1150
pubmed: 32207797
J Am Coll Surg. 2018 Jan;226(1):46-57.e1
pubmed: 28958913
J Pediatr Surg. 2021 Jun;56(6):1196-1202
pubmed: 33838903
J Pediatr Surg. 2019 Aug;54(8):1680-1685
pubmed: 30518490
Ann Surg. 2011 Oct;254(4):577-85
pubmed: 21869674
Lancet. 2000 Jan 1;355(9197):25-9
pubmed: 10615887
Lancet. 2009 Nov 14;374(9702):1704-13
pubmed: 19914515
J Pediatr Surg. 2011 Sep;46(9):1689-94
pubmed: 21929975
Curr Opin Pediatr. 2015 Jun;27(3):389-94
pubmed: 25944310
Pediatrics. 2008 May;121(5):e1438-40
pubmed: 18443020
J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):61-5
pubmed: 20543720
J Hepatol. 2019 Jul;71(1):71-77
pubmed: 30876944